Gesponsert
Bharat Bio successfully completes Phase III trials of new oral cholera vaccine Hillchol
Posted
Bharat Biotech's oral cholera vaccine, Hillchol, has demonstrated successful Phase III clinical trial results, proving effective against both Ogawa and Inaba serotypes. The vaccine exhibited a significant rise in vibriocidal antibodies and maintained a strong safety profile across all age groups. With production capacity of 200 million doses, Hillchol can address the global cholera crisis and vaccine shortages.
Search
Nach Verein filtern
- National
- International
- Business
- Technology
- Health
- Ausbildung
- Sports
- Entertainment
- Travel
- Environment
- Science
- Law
- Agriculture
- Real Estate
- Opinion
- Religion
- Weather
- Automotive
- Social Issues
- Culture
- Sci-Fi & Future
Read More
AISSEE result 2025 declared: Sainik school admission results out for Class 6 and 9, Counselling next
India's private sector growth touches 13-month high in May, buoyed by services: HSBC
India's private sector experienced a significant acceleration in May, achieving its fastest...
Man tries to enter Salman's Galaxy apartment; arrested
A 23-year-old man, Jitendra Kumar Singh, was arrested for allegedly trespassing into Salman...
Prateik: Mom's family and Raj Babbar fought for my custody
Prateik Babbar has officially changed his surname to Prateik Smita Patil, honoring his late...
Merz on Lithuania visit says Russia threatens 'security in Europe'
German Chancellor Friedrich Merz warned Thursday that Russia threatened security in Europe,...
© 2025 Dununu.com : Circle of Life - Santan Social Network
Deutsch
